Certificate number:RU.77.99.11.003.Е.002454.06.17 Date of registration and renewal:01.06.2017 Dosage form: & nbspTablets with a mass of 1150 mg. Classification "Composition" & nbsp BAD - vitamin and mineral complexes Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes Supplements containing zinc, copper, manganese Supplements containing potassium and magnesium Supplements containing chromium Supplements containing selenium Supplements that support the functions of the immune system Supplements that affect energy metabolism Supplements that support the function of the cardiovascular system Composition: & nbspVitamins B12, biotin, E, C, B6, B1, calcium pantothenate, folic acid, nicotinamide, B2; Chromium (III chloride), magnesium (oxide), selenium (selenate), zinc (gluconate) Excipients: MCC (E460), starch, mono- and diglycerides of long chain fatty acids, amorphous silica E551, hypromellose E464, shellac E904, polysorbate 80 E433, gum arabic E414, magnesium stearate E470b, titanium dioxide E171, talcum E553b, olive oil, iron oxide yellow E172. Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, departments of the trade network as a biologically active food additive - an additional source of vitamins and minerals. Suggested Usage: & nbspAdults take 1 tablet a day with meals. Duration of admission is 1 month. Contraindications:Individual intolerance to food components, pregnant and lactating women. Special instructions:Before use, it is recommended to consult a doctor. Shelf life:3 years. Storage conditions:Keep out of the reach of children at a temperature of not more than + 25 ° C. Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.007721.06.14 of 25.06.2014, the expert opinion of the FGBU Research Institute for Nutrition of RAMS №72 / E-469 / b-14 of May 15, 2014. ManufacturersKvasser Pharma GmbH & Co. KG. KG GermanyKvasser Pharma GmbH & Co. KG. KG / Queisser Pharma GmbH & Co.KG, Schleswiger Strasse 74 24941 Flensburg (Germany). Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation Information update date: & nbsp01.09.2017 Instructions